# Replimune Group, Inc.: Form 8-K, filed Jun 3, 2022

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2022-06-03
- Accepted by EDGAR: Jun 3, 2022, 08:10 ET
- Period: 2022-05-31
- Accession: 0001104659-22-067870
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465922067870/tm2217593d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465922067870/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465922067870/tm2217593d1_8k.htm

Filed Jun 3, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-067870. Last ingested by Listed: Nov 3, 2026, 23:32 ET. No prices; not investment advice.